NO2882743T3 - - Google Patents
Info
- Publication number
- NO2882743T3 NO2882743T3 NO13742640A NO13742640A NO2882743T3 NO 2882743 T3 NO2882743 T3 NO 2882743T3 NO 13742640 A NO13742640 A NO 13742640A NO 13742640 A NO13742640 A NO 13742640A NO 2882743 T3 NO2882743 T3 NO 2882743T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1213486.2A GB201213486D0 (en) | 2012-07-30 | 2012-07-30 | Quinone compounds and their uses for the treatment of cancer |
PCT/EP2013/065968 WO2014020012A1 (en) | 2012-07-30 | 2013-07-30 | Quinone compounds and their uses for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2882743T3 true NO2882743T3 (es) | 2018-05-12 |
Family
ID=46881339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO13742640A NO2882743T3 (es) | 2012-07-30 | 2013-07-30 |
Country Status (17)
Country | Link |
---|---|
US (1) | US9266829B2 (es) |
EP (1) | EP2882743B1 (es) |
JP (1) | JP6317742B2 (es) |
KR (1) | KR102142164B1 (es) |
CN (1) | CN104583200B (es) |
AU (1) | AU2013298653B2 (es) |
BR (1) | BR112015001837B1 (es) |
CA (1) | CA2880021C (es) |
DK (1) | DK2882743T3 (es) |
ES (1) | ES2662917T3 (es) |
GB (2) | GB201213486D0 (es) |
HK (1) | HK1209111A1 (es) |
IN (1) | IN2015DN01223A (es) |
MX (1) | MX361650B (es) |
NO (1) | NO2882743T3 (es) |
RU (1) | RU2688675C2 (es) |
WO (1) | WO2014020012A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156744A (en) * | 1998-03-19 | 2000-12-05 | Cancer Research Campaign Tech (London) | DT-diaphorase directed anti-tumor agents |
JP2008503579A (ja) * | 2004-06-21 | 2008-02-07 | ハッチソン メディファーマ エンタープライジズ リミテッド | 癌の化学療法 |
TWI434684B (zh) * | 2007-03-13 | 2014-04-21 | Spectrum Pharmaceuticals Inc | 經尿道切除術後的膀胱內阿帕吉坤投藥 |
-
2012
- 2012-07-30 GB GBGB1213486.2A patent/GB201213486D0/en not_active Ceased
-
2013
- 2013-07-30 JP JP2015524762A patent/JP6317742B2/ja not_active Expired - Fee Related
- 2013-07-30 EP EP13742640.9A patent/EP2882743B1/en not_active Not-in-force
- 2013-07-30 IN IN1223DEN2015 patent/IN2015DN01223A/en unknown
- 2013-07-30 MX MX2015000969A patent/MX361650B/es active IP Right Grant
- 2013-07-30 CA CA2880021A patent/CA2880021C/en not_active Expired - Fee Related
- 2013-07-30 DK DK13742640.9T patent/DK2882743T3/en active
- 2013-07-30 ES ES13742640.9T patent/ES2662917T3/es active Active
- 2013-07-30 WO PCT/EP2013/065968 patent/WO2014020012A1/en active Application Filing
- 2013-07-30 AU AU2013298653A patent/AU2013298653B2/en not_active Ceased
- 2013-07-30 US US14/418,394 patent/US9266829B2/en not_active Expired - Fee Related
- 2013-07-30 GB GB1422799.5A patent/GB2519004B/en not_active Expired - Fee Related
- 2013-07-30 KR KR1020157002128A patent/KR102142164B1/ko active IP Right Grant
- 2013-07-30 BR BR112015001837-8A patent/BR112015001837B1/pt not_active IP Right Cessation
- 2013-07-30 RU RU2015105036A patent/RU2688675C2/ru not_active IP Right Cessation
- 2013-07-30 NO NO13742640A patent/NO2882743T3/no unknown
- 2013-07-30 CN CN201380040388.1A patent/CN104583200B/zh not_active Expired - Fee Related
-
2015
- 2015-10-06 HK HK15109758.6A patent/HK1209111A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN104583200A (zh) | 2015-04-29 |
US20150210639A1 (en) | 2015-07-30 |
IN2015DN01223A (es) | 2015-06-26 |
HK1209111A1 (zh) | 2016-03-24 |
BR112015001837A2 (pt) | 2017-07-04 |
AU2013298653B2 (en) | 2017-10-19 |
ES2662917T3 (es) | 2018-04-10 |
WO2014020012A1 (en) | 2014-02-06 |
CA2880021A1 (en) | 2014-02-06 |
GB2519004A (en) | 2015-04-08 |
EP2882743B1 (en) | 2017-12-13 |
JP6317742B2 (ja) | 2018-04-25 |
KR102142164B1 (ko) | 2020-08-06 |
JP2015524815A (ja) | 2015-08-27 |
CA2880021C (en) | 2020-01-14 |
BR112015001837B1 (pt) | 2021-11-16 |
RU2015105036A (ru) | 2016-09-20 |
CN104583200B (zh) | 2017-07-25 |
KR20150036215A (ko) | 2015-04-07 |
DK2882743T3 (en) | 2018-03-12 |
AU2013298653A1 (en) | 2015-02-19 |
GB2519004B (en) | 2016-03-30 |
MX2015000969A (es) | 2015-09-23 |
GB201213486D0 (en) | 2012-09-12 |
EP2882743A1 (en) | 2015-06-17 |
RU2688675C2 (ru) | 2019-05-22 |
MX361650B (es) | 2018-12-13 |
US9266829B2 (en) | 2016-02-23 |